The Latest in Follicular Lymphoma

Idelalisib use halted in six combo therapy trials, FDA announces

March 15, 2016

AEs prompt EMA review of idelalisib

March 13, 2016

Follicular Lymphoma

Follicular lymphoma: Quantitative PET/CT measures for detecting bone marrow involvement

March 10, 2016

Follicular Lymphoma

Germline mutations linked to hematologic malignancies

March 10, 2016

Follicular Lymphoma

Teens’ weight, height linked to risk of NHL

February 22, 2016

Follicular Lymphoma

NICE issues draft guideline for NHL

February 1, 2016

Follicular Lymphoma

Mutations could be therapeutic target for FL

January 5, 2016

Follicular Lymphoma

EZH2 inhibitor can produce durable responses

December 31, 2015

Follicular Lymphoma

Triplet disappoints in follicular lymphoma trial

December 11, 2015

Follicular Lymphoma

Trial of ofatumumab in FL stopped early

November 25, 2015

Follicular Lymphoma

Companies abuse orphan drug designation, team says

November 23, 2015

Follicular Lymphoma

Drug ‘life-changing’ for CLL patients in phase 1 trial

November 12, 2015

Follicular Lymphoma

Inhibitor exhibits ‘modest’ activity in lymphoma

November 12, 2015

Follicular Lymphoma

ITC 2015: Review IDs features to aid thyroid lymphoma diagnosis

November 10, 2015

Follicular Lymphoma

New therapies finding their place in management of follicular lymphoma

November 5, 2015

Follicular Lymphoma